FDA Inspection 1211443 — Amar J. Gajjar, M.D.
The FDA completed an inspection of Amar J. Gajjar, M.D. on July 21, 2023 in Memphis, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 21, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Memphis, TN (United States)
Additional Details
Clinical Investigator (CI)